In 2016, the increase of notified norovirus cases in the winter season was unexpectedly strong and early ([Figure 1](#f1){ref-type="fig"}) in Germany. In November 2016, 14,872 laboratory-confirmed cases were reported to the national public health authority compared with a median of 7,810 cases in the same month of the previous five years. This may be due to a new variant's ability to escape herd immunity to the previously circulating strains. In this study, we conducted a phylogenetic analysis of the currently circulating norovirus strains in order to assess whether one or several new strains could be responsible for the current steep rise in norovirus cases.

![Laboratory-confirmed norovirus infections by calendar week and year of notification, compared previous seasons, Germany, week 26 2016--week 2 2017 (n = 56,384)](eurosurv-22-30447-f1){#f1}

Sample collection and molecular characterisation
================================================

The Consultant Laboratories (CL) and National Reference centre (NRC) are officially appointed and funded by the German Federal Ministry of Health and play a central role in detection and prevention of infection disease in Germany. The coordination of the CL and NRC is hosted by the Robert Koch-Institute. The CL for norovirus at the Robert Koch-Institute is focused on the molecular surveillance of viral gastroenteritis pathogens, especially noroviruses. For genotyping analysis, stool specimens from norovirus-positive outbreaks were sent to the CL by diagnostic laboratories, physicians and local public health authorities. Between September and December 2016, 240 norovirus positive stool samples from patients with norovirus-associated AGE from 13 federal states of Germany were analysed at the CL for noroviruses. Altogether 175 samples were associated with 69 outbreaks, mainly in childcare facilities (n = 39 outbreaks) and nursing homes (n = 12 outbreaks) in 11 of 16 federal states (Baden-Wuerttemberg, Bavaria, Berlin, Hesse, Lower Saxony, Mecklenburg-Western Pomerania, North Rhine-Westphalia, Rhineland-Palatinate, Saxony, Schleswig-Holstein and Thuringia). Altogether 65 samples were from sporadic AGE and were sent by hospitals and diagnostics laboratories from six federal states (Baden-Wuerttemberg, Berlin, Brandenburg, Hamburg, Lower Saxony and North Rhine-Westphalia).

Samples were genotyped as previously described \[[@r6]\] by phylogenetic analysis of ORF1 and ORF2 sequences. To determine the recombination breakpoint, 14 samples of the new norovirus recombinant were analysed in addition, using a newly established semi-nested RT-PCR spanning the 3' end of the ORF1 and the P2 domain. In brief, RT-PCR reactions were performed using SuperScriptIII One-Step RT-PCR system Platinum TAQ DNA Polymerase (Thermo Fisher, Walthman MA, US) and primer sets NV1a (5'-ATGAATATGAATGAAGATGG-3'), NV1b (5'-ATGAACACAATAGAAGATGG-3'), NV348a (5'-GGTTRACCCARGAATCAAA-3'), NV348b (5'-GRTTMACCCAAGAITCAAA-3') and NV348c (5'-GRTTRACCCAIACTTCAAA-3') for the first PCR (2328 bp fragment). The second PCR reaction was carried out using the HotStarTaq Master Mix Kit (Qiagen, Hildesheim, Germany) and primers NV6 (5'-TACCACTATGATGCAGATTA-3'), NV6a (5'-TATCACTATGATGCTGACTA-3'), NV348a, NV348b, NV348c. PCR conditions were 5 min at 55 °C, 55 min at 45 °C, 2 min at 94 °C, followed by 40 cycles of 15 s at 94 °C, 30 s at 45 °C, 3 min at 68 °C and finally 5 min at 68 °C. The resulting 2,274 bp amplicons were subjected to direct sequencing. Nucleotide sequences of these samples were submitted to the GenBank database with the accession numbers KY357449 to KY357462.

Molecular genetic results
=========================

We identified emerging recombinant norovirus strains previously not described in Germany in outbreaks or in sporadic cases of AGE. Typing results of all 240 analysed samples are shown in the [Table](#t1){ref-type="table"}.

###### Distribution of norovirus genotypes detected in samples sent to the Consultant Laboratory (outbreaks vs. sporadic cases of acute gastroenteritis), Germany, September--December 2016 (n = 65 samples from sporadic cases, n = 175 samples from 69 outbreaks)

  Norovirus genotype       Sporadic cases   Outbreaks            
  ------------------------ ---------------- ----------- -------- ----------
  GI.P1-GI.1               0                0           1        1.4
  GI.P3-GI.3               3                4.6         2        2.9
  GI.P4-GI.4               1                1.5         3        4.3
  GI.P5-GI.5               0                0           1        1.4
  GI.Pb-GI.6               0                0           2        2.9
  GII.P2-GII.2             1                1.5         0        0
  GII.P4 2009-GII.4 2012   5                7.7         7        10.1
  GII.P7-GII.6             1                1.5         4        5.8
  GII.P7-GII.7             0                0           3        4.3
  GII.P8-GII.8             0                0           1        1.4
  **GII.P16-GII.2**        **31**           **47.7**    **29**   **42.0**
  GII.P16-GII.4 2012       7                10.8        7        10.1
  GII.P17-GII.17           0                0           6        8.7
  GII.P21-GII.3            2                3.1         1        1.4
  GII.P21-GII.13           1                1.5         0        0
  GII.Pe-GII.4 2012        12               18.5        2        2.9
  GII.Pg-GII.1             1                1.5         0        0
  **Total**                **65**           **100**     **69**   **100**

The phylogenetic analysis revealed a recombination of GII.P16 (ORF1) and GII.2 (ORF2) strains ([Figures 2](#f2){ref-type="fig"} and [3](#f3){ref-type="fig"}). Using SimPlot analysis, the recombination point could be mapped to the ORF1/ORF2 junction region at nucleotide positions 732--734 (data not shown). The recombinant strain GII.P16-GII.2 was detected in 29 of 69 investigated outbreaks, in nine of the 11 federal states of Germany that had outbreaks (Baden-Wuerttemberg, Bavaria, Berlin, Hesse, Lower Saxony, Mecklenburg-Western Pomerania, North Rhine-Westphalia, Rhineland-Palatinate and Thuringia) and was considered as the aetiological agents in 31 of 65 cases of sporadic AGE. The new recombinant was detected in specimens obtained from the sporadic cases in four hospitals in Berlin, North Rhine-Westphalia, Baden-Wuerttemberg and Lower Saxony. Besides the new recombinant strain, the well-known norovirus genotypes GI.P3-GI.3 and GII.P17-GII.17 and the recombinant strains GII.Pe-GII.4 2012 and GII.P4 2009-GII.4 2012 were found co-circulating, were but less frequently detected in the current season.

![Phylogenetic analysis based on the nucleotide sequence of a 357 bp region (ORF1) of genogroup II norovirus, Germany, 2016/17 (n = 14 representative samples)](eurosurv-22-30447-f2){#f2}

![Phylogenetic analysis based on the nucleotide sequence of a 628 bp region of the P2 domain (ORF2) of genogroup II noroviruses, Germany, 2016/17 (n = 14 representative samples)](eurosurv-22-30447-f3){#f3}

Discussion
==========

We found a new norovirus strain GII.P16-GII.2 in samples from sporadic AGE and from norovirus outbreaks derived from nine federal states of Germany. It was recently shown that the emergence of new GII.4 norovirus variants can result in an increasing number of reported norovirus infection \[[@r5]\]. This has already been observed in Germany in the season 2007/08 which was also characterised by an early rise and high total number of notified norovirus infections, with most of the analysed outbreaks caused by the new epidemic variant GII.4 2006b \[[@r7]\]. Another example is the emergence of a novel variant GII.P17-GII.17 in the season 2014/15, which was first genotyped in China and Japan and replaced the previously dominant genotype GII.Pe-GII.4 2012 with an increased outbreak activity \[[@r8],[@r9]\]. The new 2016 GII.P16-GII.2 recombinant has sporadically been reported to the international molecular surveillance database NoroNet from Australia, Finland, France and Russia, and previously from Japan and China \[[@r10],[@r11]\], suggesting a worldwide distribution.

So far, it is unclear whether the new recombinant is associated with more severe symptoms. Further molecular and epidemiological investigations are needed to assess whether the emerging new recombinant norovirus strain GII.P16-GII.2 can replace the predominant GII.Pe-GII.4 2012 strain and how this will affect outbreak sizes, course of disease and herd immunity of the population, not only in Germany but also in other countries in Europe.
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